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Controlled and randomized study of oral versus intravenous calcitriol
in the treatment of renal osteodystrophy. 0. Bacchini, F. Fabrizi, M.
Corti, S. Andrulii, 0. Pontoriero, and F. Locatelli, Nephrology and
Dialysis Division, Hospital of Lecco, Italy. The aim of this prospective
and randomized study was to evaluate the effect of oral and intravenous
calcitriol, given at the end of each dialysis for a period of 16 weeks in
chronic hemodialysis patients. The calcitriol doses (0.5 g) were
gradually increased to obtain a good control of secondary hyperpara-
thyroidism; if necessary, we used a lesser calcium dialysate concentra-
tion (2.5 mEq/liter) to reduce the risk of hypercalcemia. The patients
were randomized into two groups: (1) oral calcitriol, (2) intravenous
calcitriol. The patients were stratified into two subgroups: (A) total
serum calcemia >10 mgldl; (B) total serum calcemia <10 mg/dl at the
beginning of the study. We evaluated 20 patients, 10 in subgroup A and
10 in subgroup B, mean age 51.6 13.8 years, mean hemodialytic age
84.5 57.6 months. In subgroup B, we observed that the thrice weekly
administration of intravenous and oral calcitriol resulted in a fall in
serum i-PTH with a raise in the level of serum ionized calcium
concentration, since from the first month of treatment the mean dosage
at the first month was: oral calcitriol 4.5 and intravenous 5.1 pg/week.
The incidence of hypercalcemic crisis wasn't different between the two
groups. In subgroup A, we observed that the administration of intrave-
nous calcitriol resulted in a fall (6 1%) in serum i-PTH, since from the
first month, before changes in serum ionized calcium concentration.
The mean dosage of calcitriol at this time was 4.5 ag/week. In the
subgroup A patients, we also observed that the administration of oral
calcitriol resulted in a fall (29%) in serum i-PTH only after the second
month, with a raise of serum ionized calcium concentration. The mean
dosage at the first month was 3.7 ag/week with the same incidence of
hypercalcemic crisis. In summary, in patients with baseline total serum
calcium concentration <10 mgldl, intravenous and oral calcitriol are
effective. While in patients with baseline total serum calcium concen-
tration >10 mgldl, intravenous calcitriol seems to be more effective and
rapid.
Adynamic bone disease (ABD) not related to aluminum (Al) toxicity: An
iatrogenic condition? A. Baretta, B. Pagliari, E. Minola, A. Sidoti, F.
Samd, V. De Cristofaro, Servizio Dialisi Ospedale Civile Sondrio,
Anatomia Pat. Ospedale Niguarda, Milano, Italy. ABD is an uncom-
mon type of osteopathy among dialysis patients, usually associated with
Al overload. Recently an increasing incidence of this disease has been
reported even in the absence of Al deposition. A histological pattern of
ABD was found in six out of 48 dialysis patients submitted to bone
biopsy (BB). Mean age was 56 12 years, mean duration of dialysis
was 52 38 months; five patients were on hemodialysis (HD) and one
on CAPD. ABD was defined according to the following features: bone
formation rate (BFR) < 0.033 3//.L2/day; active osteoid surface (AOS)
< 1.5%. Al and iron deposits were excluded by specific stains. One
patient was diabetic. During the year preceding the BB, all the patients
had been treated with oral calcitriol. Five patients were given calcium
carbonate as the only phosphate binder. After BB calcitriol in all was
stopped. Calcium carbonate was replaced by Al(OH)3 in two patients
and reduced in the other two. Plasma level of PTH increased from 13.2
9.2 to 96.8 49 pg/ml (P < 0.01) after calcitriol withdrawal. Blood
ionized calcium fell from 1.29 to 1.21 mmol/liter (P <0.05). Serum
levels of alkaline phosphatase, Al and phosphate did not change
significantly. There were 25 events of hypercalcemia in all the patients
during the year preceding the BB and only two events during the
following period. A second BB performed in one patient six months
after calcitriol withdrawal showed an increased bone turnover (BFR
from 0.017 to 0.05 p3/p2/day). To conclude, ABD is not rare in dialysis
patients. It is characterized by low PTH levels and by a trend to develop
hypercalcemia. In the absence of other factors inhibiting bone turnover,
ABD can be due to prolonged PTH suppression related to calcitriol
and/or calcium carbonate.
Feline Immunodeficiency virus (FIV)-associated nephropathy in domes-
tic cats: An animal model of HIV-nephropathy. P. Barsotti, F. Abramo,
E. Taccini, G. Malvaldi, M. Bendinelli, A. Poli, University of Rome
"La Sapienza": Department of Human Biopathology and University of
Pisa, Departments of Animal Pathology and Biomedicine, Rome, Italy.
FlY is a newly discovered lentivirus isolated from domestic cats with an
acquired immunodeficiency syndrome-like condition. Unspecified renal
abnormalities were reported in some infected cats. In the present report
morphological and clinical aspects of the nephropathy observed in cats
naturally infected with FlY are described in detail. Fifteen FIV-infected
cats were examined: they included 11 males and four females ranging in
age from 3.5 to 13 years. Proteinuria was present in 14 of 15 cats (>1
g/liter in 7 animals). BUN values were greater than normal in 11 cats (80
to 327 mg/dl vs. 20 to 65 mg/dl); eight of these had increased serum
creatinine values (1.7 to 3.2 mg/dl vs. l.6 mg/dl). At necropsy, blocks
of renal tissue were collected for histological, ultrastructural and IF
studies. Renal tissue damage was evident in 12 of 15 animals. It
included glomerular lesions (consisting of a diffuse increase of mesan-
gial matrix and/or a focal and segmental sclerosis) as well as tubulo-
interstitial lesions (consisting of focal tubular degenerative changes,
focal tubular ectasia, prominent interstitial inflammation of lympho-
cytes and plasma cells and occasional interstitial fibrosis). Glomeruli
were positive for 1gM and C3, with coarsely granular deposits in
mesangium and in a few peripheral capillary walls. Our findings
demonstrated that naturally Fl V-infected cats may have renal disorders
that share considerable features with HIV-related nephropathy. Thus,
FIV-infected cats may also represent a useful animal model for this
aspect of HIV-induced pathology.
Erythroid progenitor response to interleukin-3 in chronic renal failure:
Preliminary results. C. Brunati, M.D. Cappellini, T. De Feo, I. Ste-
fanoni, 0. Rombolà, G. Civati, L. Ballerini, G. Fiorelli, andL. Minetti,
Renal Unit, E.O. Niguarda-Ca' Granda, Milan, and Institute of Inter-
nal Medicine and Physiopathology, University of Milan, italy. Accord-
ing to our previous studies, in some patients with marked anemia on
regular hemodialytic treatment (RHDT) a reduced number of circulat-
ing erythroid progenitor cells, burst forming unit-erythroid (BFU-E), is
present and is correlated with a reduced response to recombinant
human erythropoietin (rHuEpo) therapy in vivo. It is not known if the
reduction of BFU-E pool in uremia is due to a reduced production of
burst promoting interleukins or to a reduced response to stimulatory
factors. In order to evaluate this last hypothesis, BFU-E were collected
from peripheral blood of four normal subjects (NS) and nine patients
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(Hb 6.9 0.7 g/dl) on RHDT and were cultured according to Iscove
method with four U/mi of rHuEpo (Cilag, Ortho) or 4 U/mI of rHuEpo
+ 20 p1/mi of IL-3 (Sandoz). In two patients and two NS different
cultures with increasing amounts of IL-3 (10, 15, 20 1d/ml) were
performed. In NS the addition of IL-3 to the culture medium increased
the number of BFU-E: the percentage of increment was 11 7%. In
patients the addition of IL-3 to the culture medium increased signifi-
cantly the number of BFU-E (from 16.7 8.1 to 31.6 11.2 col/lO
cells, P < 0.05). In four patients the percentage of increment was higher
than 100%. In NS the response to IL-3 was dose dependent and the
plateau was observed at 20 p1/mi, while it was observed at 10 p1/ml in
one patient and at 15 4/mI in the other. Conclusions: these preliminary
results suggest that BFU-E response to IL-3 is not reduced in chronic
renal failure. In some patients a response higher than in NS is present.
In patients with a basal reduced pool of BFU-E, a treatment in vivo with
IL-3 associated to rHuEpo could avoid the failure of this hematopoietic
stem cell compartment to replenish the pool of more mature erythro-
poietic progenitor cells during the phase of accellerated maturation
induced by rHuEpo and could consequently improve the response to
rHuEpo therapy.
Low incidence of peritonitis with a new connection system. C. Carner-
mi, G. Cancarini, L. Manili, G. Brunori, R. Majorca, Institute and
Department of Nephrology, University and Spedali Civili, Brescia,
Italy. Since February 1990, we have been using a new system, the T set
(Baxter®) in which the dialysate outflow flushes the disinfectant out of
the line. The system has the following advantages: a single connection,
easy to handle, short time for training and a small size set. Twenty-
seven patients have been enrolled (M/F 15/12), age 58 Il years.
Fifteen were new patients (group A) and twelve were treated before
with a different device. Reasons for change: eight patients would rather
use the new device for aesthetical reasons (group B), and four were
shifted because of high incidence of peritonitis (P, group C). Through-
out 410 months/p follow-up (mean 15 6; range 3 to 23) seven episodes
of P occurred, with an incidence of 1/58 p-rn.
Group Follow-up Peritonitis Incidence
A 238 p-rn 2 1/119 p-m
B,Tset 119p-rn I 1/ll9p-m
B, previous set 413 p-m 13 1/32 p-rn
C, T set 53 p-rn 4 1/13 p-rn
C, previous set 292 p-m 17 1/17 p-rn
In group A two incidences of P occurred, both in the same patient (both:
Staph. albus). In group B, only one incidence of P occurred during a
tunnel infection, and the same microorganism was cultured (Pseudo-
monas aer). With the previous set in group B 13 P incidences occurred:
four gram-positive, six gram-negative and three no growth. In group C,
with the new set four Pineidences occurred: three gram negative and
one Klebsiella + E. Coli + Strep. Faecalis + Candida due to bowel
perforation. With the previous set 17 P incidences occurred: five
gram-positive, nine gram-negative and three no growth. This study,
prospective and non-randomized, shows a very low incidence of P in
the new patients and in those patients shifted for reasons other than
infections (357 m-p; 3 episodes: 1/119 m-p). In the patients with a high
incidence of P during the former period, we did not observe any
improvement. It must be pointed out that all infections observed on the
new system were gram-negative. It could be possible that these
infections had an endogenous cause that cannot be prevented by any
connection system.
Intra- and extraceflular amino acids (AA) in very young children on
continuous ambulatory peritoneal dialysis (CAPD). A. Canepa, J.C.
Div mo Filho, F. Perfumo, A. Carrea, P. Ancarani, R. Gusmano, J.
Bergstrom, Nephrology Department, G. Gaslini Intitute, Genoa, Italy,
Department of Renal Medicine, Huddinge University Hospital, Karol-
linska Institute, Stockholm, Sweden. The study involved four infants
with chronic renal failure who started CAPD at an age of 12 3.4
months and on treatment from two to 23 months. Muscle biopsy and
venous blood samples were taken after an overnight fast. Samples were
obtained from rectus abdominis during surgery for hernia correction or
cathether replacement. Each patient used dialysis fluids containing
glucose 13.6 g/Iiter during the night before the investigation. Data were
compared with those of a control group of 10 children with normal renal
function who were undergoing elective surgery. Informed consent was
obtained from the parents. The plasma concentrations of most of the
essential (leucine, valine, threonine, lysine) and several nonessential
(serine, glutamine, asparagine) AA were significantly lower than in the
controls. By contrast, the muscle intracellular-free essential AA con-
centrations, except leucine, did not differ significantly from values in
the controls, whereas among the nonessential AA, glutamic and aspar-
tic acids showed significantly increased intracellular concentrations.
The muscle free amino acid pattern is less abnormal in CAPD children
than in end-stage renal failure or hemodialyzed patients. Such findings
could be related to a modification of AA metabolism in CAPD, probably
related to hyperinsulinism. The decrease in plasma AA levels might be
attributed not only to the chronic AA losses with the effluent dialysis
fluid, but rather to a shift, probably insulin related, of the AA from the
extracellular to the intracellular space.
Leukocyte trapping in dialyzers: A possible source of immunodepres-
sion. A. Castiglione, C. Ranzini, M. Bianchi, G. d'Aloya, B. Losi, C.
Fabbri, M. Beccari, M. Romagnoni, G. Cavaliere, G. Veneroni, G.
Sorgato, Departments of Nephrology and Immunohematology, Fate-
benefratelli and Ofta/mico Hospital, Milano, Italy. Alterations of the
immune system in uremic patients are well known. The role of
hemodialysis in perpetuating or amplifying those abnormalities consti-
tutes an open field of research. We studied white blood cells eluted at
the end of hemodialysis or ultrafiltration in different dialyzers: cu-
prophane (CU), polyacrylonitrile (PAN), polymethylmethacrylate
(PMMA), polysulphone (PS) and cellulose acetate (CA). Leukocyte
subsets were analyzed using monoclonal antibodies by flow cytofluo-
rimetry. An elevated number of WBCs was present in all filters (highest
with CU membranes); ultrafiltration decreased the per cent amount of
monocytes and PMN. Analysis of lymphocyte subsets revealed an
important percent increase of B cells in all dialyzers. A selective
tropism of T lymphocytes for PAN membranes was also noted. The
presumable number of eluted WBC5/per year/per patient ranged from
1.4 (PS) to 14 (CU) milliards; similar values were observed in platelet-
apheresis long-term volunteer donors in which laboratory alterations of
the immune system were documented. A leukoapheretic effect of
hemodialysis is suggested as a contribution in the status of immunode-
pression in hernodialysis patients. Elution of leukocytes from dialyzers
may be considered as a parameter in the evaluation of biocompatibility
of dialysis membranes.
Effect of phosphate removal (PR) on Mg and Ca mass-balance (MB)
during acetate-free biofiltration (AFB). C. Colturi, F. SamO, B. Pagliari,
A. Sidoti, A. Masa, V. De Cristofaro, Renal Unit, Ospedale Civile
Sondrio, Italy. Ipophosphoremia resulting from PR may affect Mg and
Ca MB, shifting these cations from the bone. To assess this hypothesis,
21 patients on chronic HD underwent AFB for three hours, with 6 liters
postdiluting Ca free replacement fluid and [Ca] and [Mg] dialysate,
respectively (1.97 .05 and 0.39 .08 mmollliter.) Blood and dialysate
samples were analyzed for ionized Ca (Cal), total Ca (CaT), Mg and P
at 0', 30', 90', 120', 180'. Ca, Mg and P transport (J) and MB were
calculated by fractional collection of whole effluent at 30', 90', 120',
180' in accordance with the formula: (Vout x Cout) — (Yin x Cin)/time,
where Cm = mean value of three measurements and Vjn = Vout —
UFR. The positive sign = negative MB (study A). The same patients
underwent AFB sessions with identical features, but with P e.v.
constant infusion (NaH2PO4 35.5 2.5 mmol) to maintain constant
phosphoremia and to greatly reduce PR (study B). Statistical calcula-
tions were performed using paired Student test and by linear regression
analysis.
A B
DF Ca mmol/liter 0.61 0.1 0.59 0.1
DF Mg mmollliter 0.54 0.02 0.56 0.2
P mmol/liter 1.55 0.52 1.6 0.63
UFR mI/rn' 45.8 5 46.3 4
D% Cal 5.8 7.6 5.42 8.5
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A B
D% CaTb 4.81 9.1 1.77 10
D%Mg —31.12±7.85 —31.94±7.42
MTCa mmol —3.91 4.5 —3.81 4.1
MTMg mmol 7.34 2.3 8.52 3.9
MTPmmol 21.6±5.3a 1.7±9.9
Abbreviations are; DF, driving force; D%, variation % beginning to
end of session
ap < .001
b corrected for hemoconcentration
Ca and Mg plasmatic and J kinetics did not change in A or B, nor did
CaMB and MgMB. CaMB was significantly correlated with D%Cal and
D%CaT in A and B (P < .0 1), suggesting the Ca gain as the major cause
of dialysis hypercalcemia. A similar result, although in the opposite
direction, was observed for MgMB and D%Mg (P < .05). Moreover,
CaMB, but not MgMB, was significantly correlated with PR in A (P <
.01) and B (P < .05; the less negative the CaMB the higher the PR). In
conclusion, a constant phosphoremia does not influence CaMB or
MgMB in AFB, yet the correlation between CaMB and PR, even in B,
suggests a positive influence of Ca gain on PR, likely to act on
phosphate transport across the cell membrane.
Effects and mechanisms of action of anti-aldosterone drugs in Banter's
Syndrome (BS). G. Colussi, G. Rombolá, M. Macaluso, L. Minetti,
Division of Nephrology and Dialysis, Niguarda-Ca' Granda Hospital,
Milan, Italy. The effects of spironalactone (S), 300 mg/day for six to
nine months (2 patients) and amiloride (A), 15 and 10 mg/day for two
weeks to three months (2 patients) have been studied in four BS patients
with a "distal" (that is, past the Henle's loop) defect according to
maximal free water clearances alter furosemide administration (Barto-
Ii's methodology). K increased in all (3.27 0.37 vs. 2.44 0.42
mEq/liter, P < 0.05); HCO3 (26.0 2.2 vs. 27.7 1.1 mEq/liter) and
arterial pH (7.44 0.04 vs. 7.46 0.02), as well as Na and P1, did not
change significantly. K changes were higher in patients on S than A
(1.34 0.38 vs. 0.46 0.21 mEq/liter, P < 0.01). Daily K excretion did
not change, but FEK fell (17 6 vs. 28 5%, P < 0.01), indicating
reduced distal tubule K secretion; plasma renin (27.4 13 vs. 9.3 5.5
ng/ml/hr, P < 0.01) and aldosterone (87.2 72.8 vs. 16.5 3.3 ng/dl, P
<0.01) markedly increased, and Cr fell (66 21 vs. 88 18 mI/mm,
P < 0.05), indicating ECV contraction. Despite increased A1d,,, esti-
mated transtubular K gradient fell in three patients in whom it was
available (8.1 2.6 vs. 11.0 3.6, P < 0.05), confirming blunted
aldosterone tubular effect. According to free water clearance studies,
fractional reabsorption of fluid delivered past the Henle's loop fell in
patients taking S (from 58.6 to 38.4 and 62.3 to 44.2%, respectively) but
not in patients on A; absolute delivery to post-Henle sites did not
change (5.9 0.9 vs. 5.8 2.4 mI/mm, P = NS). In conclusion,
anti-aldosterone drugs are effective in correcting hypokalemia in pa-
tients with BS due to a 'post-Henle" tubule defect, apparently by
inhibiting tubular K secretion without changes in fluid delivery to
post-Henle sites; at dosages used, S is more effective than A. ECV
contraction appears to worsen, though without apparent adverse symp-
toms.
Flow cytometry evaluation of urinary sediment in renal transplanta-
tion. A. Nanni Costa, S. lannelli, L.B. De Sanctis, G. Liviano D'Ar-
cangelo, A. Buscaroli, C. Raimondi, L.C. Borgnino, P. Todeschini,
M.P. Scolari, S. Stefoni, V. Bonomini, Institute of Nephrology, Uni-
versity of Bologna, Italy. The value of exfoliative urinary cytology for
the diagnosis of different pathological conditions in renal transplanta-
tion is widely recognized. The method, however, has not yet gained full
acceptance, mainly because identification of the different cells in not
always possible by means of standard staining techniques. In view of its
characteristics, flow cytometry (FC) seems to represent a consistently
reliable, rapid, and innovative approach for differentiating the various
cells present in the urinary sediment and assessing the number of them.
This study gives the examination result of 233 urinary specimens from
127 transplanted patients selected according to pathology. Sediment
cells, collected from fresh urine samples, were washed, treated with a
lysing solution, resuspended in saline solution and directly analyzed in
a FACSCAN cytometer. Morphological evaluation showed; a small
number of cells in patients with stable renal function; a larger number of
cells, with predominance of lymphocytes, during acute rejection epi-
sodes (P < 0.001 vs. stable renal function); an absolute predominance
of neutrophils during bacterial infection; large-sized cellular debris in
cases of post-transplant tubular necrosis; small cell debris in cases of
cyclosporine cytotoxicity. Lymphocyte surface marker evaluation
made it possible to differentiate lymphocyte populations observed
during acute rejection episodes (activated cytotoxic T-cell, positive for
CD8 and HLA class II antigens, and NK cells) from those detected
during bacterial infection (T-cell CD4 positive). These data suggest that
urinary FC may be a reliable diagnostic tool in clinical renal transplan-
tation.
Reduced branched-chain ketoacid serum levels in nephrotic patients.
A. Cupisti, M. Meola, M. Luperini, S. Sanguineti, E. Falbo, M.
Meriggioli, and G. Barsotti, Institute of Clinica Medica I, Nephrology
Unit, University of Pisa, Italy. Branched-chain amino acids (BCAA)
and their nitrogen-free keto-analogues (BCKA), particularly ketoisoca-
proic acid or keto-leucine (KICA), exert well-known actions on protein
and muscle metabolism. Nephrotic patients with normal renal function
show normal plasma levels of BCAA, while their BCKA plasma levels
are unknown. Reduced serum levels of BCKA have been found in
patients with advanced chronic renal failure. The aim of this study was
to evaluate the BCKA serum levels in aephrotic patients with normal
renal function. In 12 consecutive patients (8 males, S females, 16 to 64
years) suffering from nephrotic syndrome (10 membranous glomerulo-
nephritis, 2 focal glomerulosclerosis) having a daily urinary protein loss
>4 g and a serum creatinine lower than 1.2 mg/dl, we evaluated fasting
serum levels of BCAA (Valine, Leucine, and Isoleucine) and of BCKA
(Keto-valine or Ketoisovaleric acid; KIVA, Keto-leucine or KICA;
Keto-isoleucine or Ketoisomethylvaleric acid; KIMVA). Serum BCAA
and BCKA normal values were determined in 100 consecutive normal
volunteers. The results (mean SD) are reported here;
Normals Nephrotics P
Valine nmol/ml 231 41 231 45 NS
Leucine nmol/ml 127 22 131 25 NS
Isoleucine ninol/mI 66.2 13 69.3 10.6 NS
KIVA nmol/ml 14.3 4.0 6.5 5.6 <0.001
KICA nmol/ml 34.7 11.0 11.9 9.2 <0.001
KIMVA nmol/ml 19.6 6.0 10.4 6.1 <0.001
Our data confirm that nephrotic patients, as previously reported, have
normal BCAA serum levels. On the contrary, serum BCKA levels are
significantly lower than normals, even in the presence of a normal renal
function. These abnormalities may exert a negative effect on protein
and muscle metabolism of patients with nephrotic syndrome. The
possible favorable effect of a dietary supplementation with branched-
chain ketoacids in correcting such abnormalities should be evaluated.
Color-Doppler study of ureteral jet in renal diseases. G. Curatola, C.
Zoccali, CNR Center of Clinical Physiology and Division of Nephrol-
ogy, Reggio Cal, italy. Color-Doppler of the urinary tract provides
essential morphological information of the urinary apparatus. The use
of color-Doppler in nephrology, however, has not been applied for
studying the urinary flow in the various segments of the excretory
pathways. The emptying of the ureters in the bladder occurs intermit-
tently (ureteral jet) and produces very well defined color-Doppler
images. We analyzed this phenomenom in 14 healthy subjects and in 16
patients with renal insufficiency. Six of these patients had chronic
non-obstructive kidney disease and a reduction in renal function of
various degrees (Sr 1.5 to 5.5 mg/dl), while the other 10 had a unilateral
urinary obstruction (which was complete in two cases and partial in 8
cases) and normal renal function. To amplify the ureteral jet, we
injected a Furosemide bolus (0.3 mg/kg body wt. in the patients with
normal renal function and proportionally higher doses in those with
renal failure). The time of appearance and the frequency of the ureteral
jet were recorded on video tape. In healthy subjects the ureteral jet
appeared one to four minutes after Furosemide injection (median 2
mm). The jets were symmetrical and within the first two minutes
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reached a maximum frequency of seven jets/mm. This phenomenon was
also easily recorded in patients with renal failure. The appearance of the
ureteral jet in these patients, however, was slightly delayed (to 3 to 12
mm) and the average frequency was reduced (4 jets/mm). In the eight
patients with partial urinary obstruction and normal serum creatinine
the response of the obstructed side was observed in a time lapse (2 to 10
mm) and with a frequency (S jets/mm) similar to that in patients with
renal failure. In the two patients with total unilateral obstruction no jet
was observed, even prolonging the test up to 30 minutes. The data
indicate that color-Doppler is an adequate technique for studying the
ureteral emptying into the bladder. The time of appearance and the
frequency of the ureteral jet adds dynamic information to the study of
obstructive uropathy.
Positive family history of hypertension and blood pressure increase in
young adults. D. Cusi, G.P. Lupi, M. Gatti, C. Barlassina, G. Levato,
C. Robba, P. Stella, P. Bollini, M. Pellizoni, P. Casirati, and G.
Bianchi, Chair of Nephrology, Universilá di Milano; Division of
Nephrology, Dialysis and Hypertension, Ospedale San Raffaele, Mil-
ano; Division of Dialysis Ospedale Predabissi, Melegnano, Italy. We
performed a prospective study of the blood pressure change over 15
years in two groups of young adult offspring of two normotensive
parents (ONP) and offspring of two hypertensive parents (OHP) that
were selected from a population screening in 1976. ONP had both
parents and all grandparents normotensive (N = 42); OHP had both
parents hypertensive (N = 37). Hypertension was defined according to
WHO criteria. ONP and OHP had the same age (age at screening 21.3
0.9vs. 22.4 l.0,P = NS). Bloodpressure(BP)ofallthepopulation(6247 people) was measured with standardized procedure by the same
investigator at screening and (only for ONP and OHP) at follow-up.
Eight (2 1%) of the OHP but none of the ONP were clinically hyperten-
sive at follow-up (diastolic BP  95 mm Hg). BMI was slightly greater
in OHP than ONP at screening, but the difference decreased at
follow-up. Since BMI influences BP, the data had to be adjusted. The
standardized residuals (Z) for each individuals' systolic (SYS) or
diastolic (DIA) BP at screening and at follow-up were computed using
all the population data set. They were obtained by entering age, sex,
body mass index as independent variable, with BP as the dependent one
in a set of multiple regression equations after dividing the sample in four
years intervals, with one year increment for every regression equation.
The table reports the raw data and the standardized residuals as means
SEM; comparison with unpaired 1-test:
BMI SYS
1976
ONP
OHP
P
20.6 0.4
22.7 0.5
<0.01
118 1.7
123 1.7
<0.05
1991
ONP
OHP
P
22.0 0.4
23.4 0.5
<0.05
118 1.7
129 2.1
<0.001
DIA Z-SYS Z-DIA
76 1.3
79 1.4
NS
78 1.0
87 1.2
<0.001
—0.17 0.13
0.16 0.13
NS
—0.40 0.12
0.15 0.13
<0.051
—0.12 0.13
0.17 0.12
NS
—0.36 0.09
0.40 0.14
<0.001
While BP did not change with age in ONP, it increased significantly by
about 7 mm Hg in OHP (P = NS for ONP and P < 0.001 for OHP,
paired 1-test). The analysis of the standardized residuals supports the
finding of raw data but also indicates that ONP's BP is significantly
lower than the mean of its reference population in 1991 (while it was
only slightly less than the mean at screening), diverging dramatically at
follow-up. ONP's BP behaved in the opposite way. In conclusion, as
much as 21% OHP developed clinical hypertension at a relatively young
age (37 years), while there is no tendency of BP increase with age in
ONP.
The erythrocyte as a model of kidney tubule cell. D. Cusi, E. Niutta, C.
Barlassina, P. Bollini, P. Stella, P. Casirati, M. Pellizoni, C. Robba, G.
Levato, L. Soldati, G. Bianchi, and L. Bianchi, Chair and Division of
Nephrology, Universitá di Milano and Ospedale San Raffaele, Milano,
Italy. The need of a cellular model that can be easily studied, but that
behaves in a relatively similar way to kidney tubular cells is evident in
the study of the pathophysiology of hypertension and of some nephrop-
athies. We faced this problem measuring many ion transport systems in
the erythrocytes of essential hypertensive patients (EH, N = 145) and
normotensive controls (NC, N = 96). Na-K-Cl cotransport (COT)
increased on average in the EH, was distributed bimodally (Lilliefors
test for bimodality P < 0.001) in this subgroup of patients and
unirnodally in the NC. The average increase of COT in the EH is caused
by the subgroup of patients in the high mode, comprising about 25% of
all EH. The EH with high COT have low plasma renin activity (PRA)
and fractional uric acid excretion (FE Ur%) than the EH with normal
COT and the NC (P > 0.05, ANOVA, SNK test), suggesting that they
have expanded volumes (low PRA) and increased proximal tubular
resorption (low FE Ur%). To see if high COT was associated with other
abnormalities of renal function, we tested the effect of a single dose of
furosemide 25 mg p.o. on diuresis and natriuresis in six high COT EH
and six matched normal COT male EH. Urine was collected every 30
minutes for 90 minutes before furosemide administration and for 240
minutes after it. At the beginning of the test an intravenous saline
infusion was started and lasted to the end of the test (NaCl 150 m, 2
mi/mm). The high COT EH had double water and sodium excretion as
compared to the normal COT EH (MANOVA for repeated measure-
ments). No changes from baseline or differences between groups were
observed for PRA, creatinine clearance, or blood pressure. These
results suggest that that COT activity measured in the erythrocytes
reflects the activity of COT present on the cells of the thick ascending
limb of Henle's loop, cells that are much more directly involved in the
control of sodium excretion and of blood pressure. It is possible that a
greater quantity of sodium is resorbed in these cells by COT. In
conclusion, abnormalities of erythrocyte cation transport are associated
with kidney function abnormalities and can be used to deepen our
knowledge of renal pathophysiology.
Loss of nocturnal decline of blood pressure (BP) and progression of
chronic renal failure (CRF). G. Del Rosso, L. Atnoroso, F. Rini, B.
Fiederling, E. Mastrangelo and A. Albertazzi, Department qfNephrol-
ogy, University of Chieti, Italy. Twenty CRF hypertensive patients
were selected and divided by automatic ambulatory BP monitoring into
two groups: GI had blunted (<5%) nocturnal BP decline, and G2 had
normal (>10%) nocturnal BP decline. These groups were studied for 24
months. GI and G2 consisted of 10 subjects each, comparable for age,
sex, severity of hypertension, residual GFR, underlying renal diseases
and antihypertensive drug treatment. In basal conditions and every
three months BP and HR were recorded by automatic ambulatory BP
monitoring (SL 90202, Spacelabs). At the same time GFR was assessed
by Car. After 12 months the monthly mean increase of creatinine (Cr)
was significantly higher in Gl:0.09 0.05 cng%/mo vs. G2:0.04 0.04
mg%/mo (P < .05). Therefore, in Gl we titrated the therapy for
nocturnal control. In four patients (GIR) we achieved a normalization
of 24 hours BP profile while in six patients (G1NR) the persistence of
the same blood pressure profile was documented. After 24 months Cr
was significantly higher in G1NR:0. 11 0.04 mg%/mo vs. GIR:O.04
0.02 mg%/mo (P < 0.5). In GIR Cr was roughly to G2 and the
break-point was coincided with the therapy titration. In CRF hyperten-
sive patients the blunted noctural BP decline may be associated with
faster progressing of renal failure. In "non deepers" patients antihy-
pertensive treatment should be titrated for nocturnal control in spite of
normalized mean 24 hour BP.
Effects of erythropoietin treatment (rHuEpo) on central nervous system
in uremia: Electrophysiology of nerve conduction by magnetic stimula-
tion. B. Di Paolo, L. Di Liberato, G. Catucci, B. Fiederling, A. Marini
and A. Albertazzi, Department of Nephrology, University of Chieti,
Italy. The more recent techniques of electrophysiological assessment of
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evoked potentials by faradic, galvanic and/or by magnetic stimulation
current have proven to be sensitive and useful indices of clinical state in
some neurological conditions. Furthermore, they are worthwhile in the
evaluation of brain electrical activity before and after rHuEpo treat-
ment. Our study was mainly devoted to evaluate brain electrical activity
before and after such stimulation and the effects of rHuEpo treatment
on the evoked responses. In order to evaluate the hypothesis that
theoretically anemia can be a cause of brain dysfunction in uremia, we
assessed in 18(10 M, 8 F) RDT patients, age range 35 to 58 years before
(Ti), after 12 weeks (T2) and 24 weeks (T3) of rHuEpo, some electro-
physiological tests: Visual (VEP), Brainstem (BAER) and Somatosen-
sory (SEP) Evoked Potentials (EPs). rHuEpo (Eritrogen 2000, Boeh-
ringer Mannheim) was injected subcutaneously two times a week after
dialysis in order to get Hct levels between 30 to 35%. rHuEpo induced
a decrement of latency of P100 VEP (134.2 7.9 in Ti vs. 116.5 6.9
in T2, P <
.001, and 107.6 5.7 msec in T3, P <0005) and of the four
main components of BAER. The most significant SEP changes were
P27-N35 from peroneal nerve (P <
.01), as well as an augmentation of
SEP amplitude. The magnetic stimulation permits us to achieve many
significant results in the brain cortex electrophysiology in RDT patients
treated by rHuEpo. Correction of anemia with rHuEpo leads to
significant improvement in brain function in RDT patients. Increased
Hct will lead to enhanced brain oxygen delivery, directly improving
brain metabolism. When Hct rises, cerebral blood flow falls from high
levels to normal, decreasing delivery of uremic "toxins" to the brain.
The decrease in cerebral blood flow may decrease intra-cranial pressure
and in this way may exert its beneficial effects by a rheological pathway.
A new X-linked hypophosphatemic rickets with hypercalciuria leading
to progressive renal failure. G. Enia, C. Zoccali, A. Bolino, G. Romeo,
Division of Nephrology OORR and CNR Centre of Clinical Physiology,
Reggio Cal, and institute of Molecular Genetics, University of Genua,
Italy. We have studied a family with a hitherto undescnbed X-linked
phosphate tubulopathy leading to progressive renal failure, which
differs substantially from that associated with X.linked hypophos-
phatemic rickets (XLH). The screening involved 11 subjects across
three generations: A seven year old boy had hypophosphatemia and
markedly reduced TmPO4 (0.8 mg/100 ml), severe hypercalciuria (270
mg/24 hr), proteinuria (2.2 g/24 hr) and normal GFR. A 17 year old
young man had full blown myopathy and osteomalacia, proteinuria (3
g/24 hr) and moderate renal failure. We showed marked hypophos-
phatemia (2 mg/dl) and hypercalciuria (550 mg/24 hr) with appropriately
increased 1,25 vitD3 plasma concentration (76 pg/ml) and low-normal
PTH1.84 (14 pg/mI). A 33 year old man with the same tubulopathy,
appropriately elevated 1,25 vit D3 (78 pg/mI) and disabling bone
deformities displayed severe renal failure (Scr: 6 mg/dl). Four females
(two of whom with mild symptoms of bone disease) exhibited frank
hypercalciuria. Results of linkage analysis by D2 and 99.6 DNA probes
exclude that the gene responsible for this disease is located the region
where the HDRP gene (the gene responsible for XLH) has been
mapped. The phosphate tubulopathy in this family differs from that of
XLH for the appropriate I ,2SvitD3 response to hypophosphatemia and
the accompanying hypercalciuria. This new form of X-linked hypophos.
phatemic rickets is very similar to the X-linked tubulopathy in the Gy
mice recently characterized by G.A. Davidai (JCI 85,334,1990) and is
caused by a gene mutation different from that responsible for XLH.
Osteocalcin levels in patients on continuous ambulatory peritoneal
dialysis (CAPD). A. Fabris, A. Lupo, P. Bernich, V. Ortalda, L.
Perobelli, G. Maschio, Nefrologia Medico - Laboratorio diBiochimica,
Universitd di Verona, Italy. Osteocalcin is a specific index of new bone
formation. The correlation between Osteocalcin (GLA) and other
biochemical bone parameters in dialysis patients and its possible
modification induced by the therapy is still controversial. We have
studied 49 patients (29 CAPD and 20 HD); of these, 24 patients were
treated with Calcitriol (0.5 to 1 sg/day) and calcium supplement (1
g/day) for a mean period of nine months. in addition, ALP, 25(OH)D2,
serum Ca and P and bone mineral content were determined. In CAPD
patients we also measured the GLA in the peritoneal dialysate. In
CAPD patients (see table) we observed significant decreases of the
GLA, consistent with the modifications of other parameters in patients
treated with calcitriol and calcium supplement.
Basal Calcitriol + Ca suppl. Ca suppl.
GLA ngr/ml 15.16 + 6.21 7.83 + 4.0° 10.7 + 5.l°
PCa m,nollliier 1.19 + 0.07 1.25 + 0.07° 1.20 + 0.0
GLA ngr (pent, dial.) 3.2 + 1.5 3.15 + 1.47 3.76 + 1.9
GLA vs. PTH NS r = 64o° NS
° p < 0.001
b P < 0.01
In HD patients the basal values of GLA, PCa and PTH were not
significantly different whether treated with Calcitriol or calcium supple-
ment. Our study shows that GLA is a marker of bone turnover only in
CAPD, and not in HD patients. The reasons for these differences may
be the continuous and important losses of the osteocalcin through the
peritoneal fluid.
Glomerular hypertrophy and renal failure in focal segmental glomer-
ulosclerosis. S. Feriozzi, A. Onetti Muda, G.A. Cinotti, T. Faraggiana,
Universitd degli studi 'La Sapienza" Rome, italy. Focal segmental
glomerulosclerosis (FSGS) evolves towards chronic renal failure (CRF)
with a highly variable rate; in particular, a group of patients (pts) with
a much more rapid decline of renal function (RF) has been described.
The purpose of this study was to evaluate the feasibility of using
morphometry to identify those cases with a faster decline in RF. Two
groups of patients have been studied: six (1 M and 5 F) with rapid
evolution towards CRF (Gl), and six (3 M and 3 F) without reduction in
RF during follow-up (G2). Mean age was 35.6 19.6 years (Gl) and
29.8 10.1 years (G2, P = NS). Significant proteinuria was present for
23.6 22.4 months (Gl) and for 19.6 26.2 months (G2) preceding
renal biopsy. Cortico-resistant nephrotic syndrome was present in two
patients Gi and in four patients 02; it persisted 6 9.2 months (GI) and
15.5 15.9 months (G2, P = NS). Mild/moderate arterial hypertension
was present in three patients GI only. Initial serum creatinine (IC) was
1.6 0.5 mg/dl (Gi) and 0.78 0.27 mg/dl (G2) (P = .04); final serum
creatinine was 5.6 2.1 mg/dI (GI) and 0.97 0.13 (G2) (P = .0002).
Follow-up ofGl was shorter than that ofG2 (29.3 34.7vs. 65.3 41.7
months, P = NS) since four patients of the former group had to be
placed on hemodialysis (P = .03, x2' Fisher test). Results of the
morphometric analysis of glomeruli were as follows:
Gl G2 P
Area i2 30550 5259 22667 5078 0.01
Maximum diam 2 40827 9508 30445 7224 0.02
Mean diam 193.9 15.8 161.8 16.8 0.003
Caliper diam s 328.6 20.6 260.6 36 0.001
Values of body surface area were not different between the two groups
(1.85 0.34 vs. 1.6 0.13 m2, F = NS). IC correlated with mean
diameter (P <
.05) and with Caliper diameter (P < .05). Our results
suggest that glomerular hypertrophy in the course of FSGS is correlated
with faster decline towards CRF. It might represent a compensatory
hypertrophy which would immediately precede a rapid decline towards
RF, or it might be expression of the pre-existing condition (meganeph.
ronia) which predisposes to the development of CRF.
Glomerulonephritis induced by human IgMK-IgG cryoglobulins in
mice. A. Fornasieri, M. Li, S. Armelloni, C. Pinerolo, E. Schiaffino,
R.A. Sinico, C. Schmid, G. D'Amico, Department of Nephrology and
Pathology, San Carlo Hosp, Milano, Italy. To see whether human
cryoglobulins (cryos) can induce glomerulonephritis (GM) in mice, 2
cryos IgMk-IgG from two patients with active GN (OLD and SOR), 2
cryos IgMk-lgG (TAC and GRO) and 1 1gM lambda (CHI) from three
patients without GM were purified, solubilized at 37°C and injected into
BALB/c mice, 4 mg iv., twice a day. At day 1, cryo OLD induced
mesangial deposits of human 1gM, human IgG, mouse C3 and prolifer-
ation. On day 3 monocytes were found in glomeruli along with massive
intraluminal and subendothelial deposits of 1gM, IgG and C3. On day 6
perivascular infiltrates of monocytes were also seen. Cryo SOR induced
a similar but milder form of GN, while cryos TAC GRO and CHI did not
induce GN. After administration of purified OLD or GRO IgMk or IgG,
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there was only mesangial deposition of OLD IgMk. To study possible
factors of cryo nephrotoxicity, the presence, amount and size of
complexed IgMk-IgG at 37°C were analyzed by HPLC-ELISA and
rheumatoid factor (RF) idiotypes Ccl and Lcl were assigned by
ELISA. The isoelectric points of lgMks were 4.5 to 5.5 and the
proportion of IgG subclasses were normal. This study demonstrates
that human cryo from patients with GN can induce GN in mice that
resembles the corresponding human pathology. The affinity of IgMk for
glomeruli and the unexpectedly small amount of IgMk-lgG complexes
at 37°C suggest that there is a role of in Situ binding in nephrotoxicity
which is independent of the isoelectric point, IgG subclass or RF
idiotype.
Anti.neutrophil cytoplasmic autoantibodies (ANCA) and disease activ-
ity in systemic vasculitis: A prospective study in 57 patients. G.M.
Frascà, A. Vangelista, C. Feletti, M. Di Luca, Neri Lucia, Neri Loris,
L.C. Borgnino, A. Giudicissi, V. Bonomini, Institute of Nephrology, St.
Orsola University Hospital, Bologna. Italy. Serial ANCA determina-
tions were carried out prospectively during follow-up of 27 patients
suffering from Wegener's granulomatosis (WG), and 30 patients with
microscopic polyarteritis (mPAN). ANCA were searched for by indi-
rect immunofluorescence (HF) and ELISA methods and found in 23
WG patients (a granule-reactive in 19 cases) and in 17 mPAN patients
(myeloperoxidase-reactive in 16). ANCA were detected in 19 out of 20
WG patients who entered the study during active phase and in four out
of seven WG while on remission. Among patients with mPAN, ANCA
were found in 17 out of 19 patients with active disease, and in no patient
without clinical signs of activity. Thirty patients who entered the study
with active disease and increased ANCA titer were studied for more
than six months with serial determinations during immunosuppressive
treatment. In 14 of them (47%) ANCA closely correlated with clinical
manifestations of the disease. In five patients (16%) ANCA fell within
the normal range three to six months after clinical remission was
achieved. In 11 patients (37%) ANCA never became negative despite
complete disappearance of clinical symptoms. In four patients from the
last group withdrawal of immunosuppressive drugs and steroids was not
followed by any relapse of the disease for 9 to 16 months despite
persistently abnormal ANCA titers. Our results demonstrate that
ANCA do not always correlate with the clinical course of systemic
vasculitis. Thus, they should be carefully weighed when assessing
disease activity and deciding the therapeutic regimen.
Silica exposure and ANCA positive rapidly progressive glomerulone-
phritis. G. Gregorini, L. Morassi, A. Ferioli, P. Tira, R. Tardanico, F.
Franceschini and R. Maiorca, Department of Nephrology, Pathology
and Immunology of Spedali Civili and University of Brescia, ICPS-
international Centre for Pesticide Safety, USSL 69, Busto Garolfo,
Milan, Italy. Rapidly progressive glomerulonephritis (RPGN) with
histological picture of severe crescentic glomerulonephritis is one of the
renal diseases associated with silicosis. Described patients frequently
show systemic symptoms and pulmonary hemorrhage as well. LES-like
serological abnormalities and renal immunocomplexes deposition were
found in some patients while IgA deposition was demonstrated in
others. However, in many cases the immunohistologycal picture was
compatible with paucimmune definition. No data are available on the
presence of ANCA in this group. We re-examined all male patients who
suffered of RPGN observed in our department since 1975 in order to
make the following evaluations: (1) presence of silicosis or significant
silica exposure; (2) presence of ANCA in those pts silica exposed.
Silicosis or significant silica exposure was found in 12 out of 37 pts
(33%) with RPGN. At admission, besides renal symptoms, constitu-
tional symptoms (5/12 pts), hemoptysis (7/12) and arthromyalgias were
present. Immune test revealed increased IgA titer in 7/9 patients,
increased IgG in 3/9, positive ANA test in 4/11, cryoglobulinemia in 1/9.
Only one patient showed dsDNA positive test and complement con-
sumption. Seven out of eight patients tested for ANCA showed a
positive test (6/7 with pattern P-ANCA and positive ELISA for anti-
MPO). In silica exposed patients, renal biopsies revealed crescentic
glomerulonephritis (li/il) and intracapillary necrosis (7/li). Arteriolar
fibrinoid necrosis was seen in one case. Seven out of eleven patients
showed a peculiar feature consisting in areas of nodular sclerosis in the
glomerular tuft. Immunofluorescence microscopy showed deposits of
IgG and C3 only in the patient with LES-like serological abnormalities.
In all other cases mild (+) focal positivity for 1gM (5/10) and C3 (8/10)
on mesangium andlor glomerular capillaries were present. Electron
microscopy study (3 pts) did not show any electron-dense deposits.
Polarized LM did not demonstrate any birefringement crystals. We
conclude that a great part of all male patients who develop RPGN in our
area consists of silica exposed patients. Most of these patients have
ANCA of P-ANCA and anti-MPO type and in all but one the clinical
and histopathological features are those described in ANCA positive
patients. Nodular areas of glomerular sclerosis are a peculiar finding in
this group of silica exposed ANCA positive patients.
Role of pregnancy on the evolution of renal disease. Gruppo di studio
Rene e Gravidanza, Italian Society of Nephrology (Coordinator E.
Imbasciati, Ospedale di Lodi) and Mario Negri Institute, Secretariat G.
Remuzzi, Bergamo, Italy. A multicenter retrospective study was per-
formed to evaluate the influence of pregnancy on the evolution on
underlying renal disease. Five hundred eighty-eight women with
chronic nephropathy were studied and divided into three groups: group
= nullipara (N 202), group 2 = patients who became pregnant
before the onset of nephropathy (N = 143), group 3 = patients who
became pregnant after the onset of nephropathy (N = 243). Kaplan and
Meier survival function estimates were compared for two kinds of
events: chronic renal failure (CRF, number of events: 227, percentage
of events in group 1 40%, in group 2 46% and in group 3 36%,
generalized Savage test P = 0.007) and end-stage renal failure (ESRF,
number of events: 129, percentage of events in group 1 23%, in group 2
31% and in group 3 16%, generalized Savage test P = 0.0001).
Relationship between some variables and survival time was analyzed
showing that presence of stable hypertension and "center effect" were
associated with CRF, whereas CRF and "center effect" were related to
ESRF. To take into account this information, adjustments were made in
the comparisons between survival curves, but they did not lead to any
substantial change. In conclusion, pregnancy does not alter the natural
history of nephropathy; yet, a bias in the selection of patients cannot be
excluded.
Early alteration of left ventricular diastolic function in hypertensive
uremic patients on maintenance hemodialysis. Antonio Liguori, Claudio
Napoli, Pompeo Sorice, Silvia Anna Ciafre, Attilio Di Benedetto,
Nicola Di leso, and Amedeo Varriale, Divisions of Cardiology and
Nephrology, Regional Hospital of Pellegrini, Naples, Italy; Depart-
ment of Medicine, Division of Cardiology, University of Naples, Italy;
Department of Cellular and Molecular Biology, Chapel Hill, The
University of North Carolina, USA; and Department of Molecular
Biology and Genetics, University of Rome. Italy. Cardiac structure and
morphology in chronic hemodialized patients (HD) are modified in
consequence of both vascular and neurohormonal factors. A complex
relationship between heart and kidney influences the pathophysiologi-
cal role of a variety of endogenously released hormones and neurohor-
monal factors, such as atrial natriuretic factor (ANP). Cardiac activity
is specifically affected by dialytic treatment, but the specificity of
uremic cardiomyopathy is still debated. In our previous studies we
demonstrated that an early alteration of left ventricular diastolic func-
tion (LVDF) occurred in HD patients, and this alteration is correlated
with high levels of ANP. Thus, the aim of this study was to investigate
LVDF in normotensive and hypertensive CHP. Twenty-six CHP were
studied (15 males and 11 females; hypertensive, N = lI-ASP 184 20
mm Hg, ADP 105 11 mm Hg, HR 85.2 10.7 bpm and normotensive,
N = 15-ASP 121 10mm Hg, ADP 80 8 mm Hg, HR 78.8 10.1
bpm). CHP underwent chronic hemodialytic treatment, three times a
week, from 94.6 48.1 months. All patients were examined 24 hours
after dialysis by an M-mode and two-dimensional echo-doppler
(Hewlett-Packard Sonos 100 with 2.5 to 3.5 MHz transducers). The left
ventricular end-diastolic diameter (LVEDD) was measured from a left
parasternal echo view. For assessment of LVDF measurements of
mitral inflow velocities were made, the pulsed doppler sample volume
being positioned at the level of the mitral annulus from an apical
4-chamber view. The peak velocities of early diastolic filling (PEDFV)
and atrial diastolic filling (PADFV) were thus obtained. These and
others echo-doppler measurements were performed according to stan-
dards recommended by the American Society of Echocardiography.
The results were expressed as mean Sn.
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Normotensive HD Hypertensive HD
LVEDD mm 50.5 7.2 59.3 5.2a
Shortening fraction % 38.9 3.7 37.5 7.3
PEDFV cm 78.5 13.7 61.2 11.7
PADFV cm 56.8 8.7 89.7 18.4a
PEDFV/PADFV ratio 1.4 0.7 0.7 0.31'
a p< 0.01 vs. normotensive HD; h P < 0.001 vs. normotensive HD.
PEDFV decreased significantly in hypertensive HD (P < 0.01 vs.
normotensive HD). In contrast, PADFV was higher in hypertensive HD
than normotensive HD (P < 0.01). Thus, the ratio of the two filling
velocities decreased significantly in hypertensive HD (P < 0.001 vs.
normotensive HD). These data make in evidence an impairment of both
component of LVDF. In addition, this alteration was clinical early in
hypertensive HD. Therefore, the follow-up of hypertensive HD by
several M-2D-echocardiographic and doppler controls allows us to
follow continuously the early subclinical alteration of LVDF. This fact
could make in evidence any variation with significant therapeutic
implication for hypertensive HD patients.
Serum and urine glycolate assays to differentiate hyperoxalurias. M.
Marangella, M. Petrarulo, C. Vitale, D. Cosseddu, F. Linari, Neph-
rology Division and Renal Stone Laboratory, Mauriziano, Torino,
Italy. Glyoxylate, a major precursor of oxalate (Ox), can be either
oxidized to Ox or reduced to glycolate (Gly). Thereby, Gly is a reliable
marker of oxalate biosynthesis. In order to better define hyperoxaluric
syndromes, we have measured Gly and Ox in plasma and urine from 84
subjects, including 44 idiopathic calcium stone-formers (ICaSF), eight
patients with primary hyperoxaluria type 1 (PHI), five patients with
enteric hyperoxaluria (EH), eight parents (PH parents) from four
patients with PHi, and 19 healthy subjects (HS). Gly was assayed by a
novel HPLC procedure, Ox by ion chromatography, and GFR was
assessed as creatinine clearance. Gly was 7.9 2.4 smol/liter in plasma
and 422 137 molI24 hr in urine from HS. Gly renal clearance was
about 50% the GFR and was independent of the underlying disease.
There was a close relation between Gly and Ox plasma levels. Plasma
Gly was normal in all except the PHi patients, whose Gly was always
increased (199 147 prnol/liter). Plasma Gly did not overlap with
normal, whereas urine Gly did, but only in PHi patients with impaired
GFR. Upon pyridoxine substitution (600 to 900 mg/day), plasma and
urine Ox decreased in 2/4 PHI patients, and Gly levels varied similarly.
Gly excretion was slightly increased in ICaF (535 220 smo1/24 hr, P
<0.05), but independently of urine Ox. Urine Gly was also increased in
3/8 PH parents. Gly levels were normal in all the patients with EH. We
conclude that plasma and urine Gly assays represent a valuable tool to
detect and differentiate hyperoxalurias.
Humoral and histologic effects of pulsed calcitriol (C) therapy in
hemodialysis (HD): Comparison of i.v. versus p.o. administration. S.
Mazzaferro, M. Pasquali, P. Ballanti, E. Bonucci, F. Bondatti, L.
Onorato, I. Perruzza, A. Spurio, M. Trombetta, G. Coen, Nephrology
Unit and Department of Human Biopathology, University "La Sapi-
enza", Rome, Italy. The humoral [Ca, intact-PTH (i-PTH) and AP;
basally and after two and eight months (m)] and histologic (bone biopsy,
before-after) effects of C administration i.v. or p.o., post-HD, were
compared in 10 patients (M/F:3/7; 47.1 16.9 years; HD from 106.5
55.2 m) with severe secondary hyperparathyroidism. Six patients
(group A) received C i.v., 0.015 g/Kg/HD, while four comparable
patients (group B), received the same dose p.o. In group A i-PTH
decreased from 382 327 pg/mi to 244 323 after 2 m (P < .009), but
returned to 363 360 after 8 m (P < .01 vs. 2 m; P NS vs. Bas). AP
decreased from 605 672 niU/ml to 425 516 and 420 638 after 2 and
8 m (P < .02). Ca increased (1.28 .08 vs. 1.32 0.11 mmollliter,
Bas vs. 8 m, P = NS). As for histologic data, a decrease of ObS/BS
(from 14.2 8.1 to 7.7 8.6%, P < .02) and ES/BS (from 10.7 2.4
to 7.3 3.3%, P < .02) was recorded, together with a NS reduction,
toward normal values, of all other static and dynamic parameters. In
group B i-PTH and AP showed an NS increment of mean values, with
a worsening of OS/BS (from 50 7 to 57.2 13.3%, P < 0.05) and of
ObS/BS (from 14.7 6 to 24.6 9%,P < 0.04). An NS increment was
also recorded in all other histologic parameters. In conclusion, at the
doses here employed, i.v. C exerts a transient suppression of parathy-
roid secretion in addition with a measurable therapeutic effect on bone.
The same dose of C, p.o., is unable to affect secondary hyperparathy-
roidism. The therapeutic role of blood C peaks during i.v. administra-
tion is underlined.
Factors affecting the calcium-PTH relation curve in patients with
variable degree of CRF. P. Messa, C. Vallone, G. Mioni, D. Turrin, 0.
Geatti, C. Toso, Department of Nephrology, *Institute of Nuclear
Medicine, City Hospital, Udine, Italy. The aim of the present investi-
gation was to evaluate at what level of GFR changes in the Ca-PTH
secretion curve begin and what the main causal factors are. We studied
15 male patients, aged 28 to 68 years, with Ce,. 14 to 164 mI/nun and
u-prot < 3 g/day. After a control period for basal evaluation and to
confirm the stability of the degree of renal insufficiency, the following
parameters were evaluated: (1) GFR by i.v. clearance of EDTA-Cr51;
(2) serum concentration of 1 ,25(OH)2D, 25(OH)D3, Calcitonin (CT),
intact-PTH; (3) Sensitivity (Sens), Maximal secretion of PTH (PTH-
max) and setpoint for PTH secretion (SP) by maximal hypocalcemic
stimulation test (EDTA-Na2 37.2 mg/kg/ 2 hours i.v.) and oral Calcium
(2 g) suppression test; (4) serum phosphate (Pi),TmPi/GFR. The table
shows the values of the main parameters (mean SD) and the
significance of correlation among them (the signs "-1-" or "—" indicate
a positive or negative correlation; a P < 0.05, ' = P < 0.01;" = P <
0.001).
SP mg/dl
l,25(OH)2
pg/ml
26.1 9.9
25(OH)
ng/ml
23.3 8.2
CT
pg/mi
18.1 13.4
NS NS a
4.7 1.4
Sens ng/mmol NS +a
1,330 1,191
PTH-max pg/ml b NS +"
156.3 110
PTH GFRJ1.73 m2 Pi
pg/mi mI/mm mg/dl64.8 71 45.6 29 3.2 0.6
NS NS
—c NS
NS
From these data and by means of stepwise multiple regression analysis,
it was concluded that: (1) Sens and PTH-max are the parameters of the
Ca-PTH curve that first change with the progression of CRF; further-
more, the former is mainly affected by 1 ,25(OH)2 reduction (26%), basal
PTH levels (21%, an index of receptors down-regulation) and by GFR
per se (39%). The latter was mainly affected by CT (46%), basal PTH
(39%) and GFR per se (12%); (2) SP was not increased by reduction of
GFR, and its values appeared mainly dependent on CT and basal PTH
values. No role for Pi and 25(OH) was evident in our study.
Evidence of a role of prostaglandins (PG) in glomerular hyperfiltration
of insulin dependent diabetes (IDDM). A. Montanan, P. Perinotto, G.
Giucastro, M. Serventi, G. Ragni, E. Fasoli, D. Giberti, E. Taleo, S.
Tardio, P. Minuz, A. Novarini, Semeiotica Medica, I Divisione Mcd-
ica, Parma and Clinica Medica, Verona, Italy. In order to investigate
the role of PG in glomerular hyperfiltration in IDDM, renal plasma flow
(ERPF), glomerular filtration rate (GFR), and fractional excretion of
sodium (FENa%) were measured under continuous infusion of PAH
and Inulin in seven IDDM with high GFR (IDDM-HF, baseline GFR
163 7 SEM ml/min 1.73 m2), in seven IDDM with normal GFR
(IDDM-NF, baseline GFR 104 4) and in six control subjects (C,
baseline GFR 119 4) for one hour before and after 15 minutes infusion
of lysine acetilsalycilate (ASP) 10 mg/kg body wt. Preliminary experi-
ments with such a dose of ASP had shown a 90% decline of urinary
excretion of 6-keto PGF1a. After ASP, GFR fell (143 9, —12%, 0.005
vs. baseline) in IDDM-E-IF, but not in IDDM-NF (101 2, NS) and C
(118 4, NS). ERPF showed a slight, but significant fall only in
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IDDM-HF (695 41 ml/min 1.73 m2 to 644 44, 0.05). FENa%
declined at the same extent in the three groups (0.001). Our findings,
showing a significant fall in GFR after acute PG synthesis inhibition in
IDDM-HF, but not in IDDM-NF and C, suggest an important contri-
bution of PG to the glomerular hyperfiltration of IDDM.
Calcium kinetics during paired filtration dialysis (PFD). G. Pacchiano,
C. Libetta, A. Scialó, A. Dello Russo and B. Memoli, Department of
Nephrology and Department of Biochemist,y and Medical Biotechnol-
ogy, II Faculty of Medicine, University of Naples, Italy. PFD is an
effective blood treatment resulting from the coupling of hemofiltration
and dialysis in two separated devices, a polysullone (P) and a heinophan
(H) filter, respectively. The aim of this study was to evaluate calcium
(Ca) kinetics during PFD with three different reinfusion solutions: (A)
saline (0.9% NaCI), (B) bicarbonate (HCO 40 mmolfliter), and (C)
calcium lactate (Ca 4 mmol/liter). Dialysate calcium concentration
was 1.75 mmolliiter; ultrafiltration flow rate was 50 mI/mm. The studies
were performed by simultaneously collecting three blood samples: at P
inlet (a), between P and H (b), and at H outlet (c), to measure total and
ionized calcium concentrations (mg/di). The driving force (Di) was also
calculated (as the difference between the calcium ionized concentration
in the inlet dialysate and its blood concentration) in each dialysis
session. Calcium fluxes (N, mg/mm) through P (as convective loss Ni)
and H (as diffusive uptake, N2) were separately calculated by using
total calcium concentrations. The results are reported in the following
table:
A B C
# of studies
Nl
N2
Ni + N2
6
—3.047 1.14
+2.517 l.2la
—0.413 0.69a
6
—3.310 0.80
+2.562 0.4l
—0.633 0.39a
6
—3.536 0.79
+ 1.147 0.64
+0.417 0.96
a P < 0.01 vs. C
Our results show a positive calcium kinetics only with a reinfusion
containing calcium lactate, although both Df and N2 were greatly
reduced with this kind of reinfusion.
A computerized model predicting bicarbonate (BIC) kinetics during
acetate free hemodiafiltration (AFH). A. Pacitti, M. Atti, G. Martina, S.
Alloatti, R. Bergia, A. Manzione, P. Bongiorno, F. Goia, M. Timbaldi,
A. Vercellone, Dialysis Centers of Turin (Molinette, G. Bosco), Aosta,
Biella, Chieri, Asti, Alba; Hospal SpA, BO, Italy. A model simulating
the BIC kinetics during AFB has been developed on a commercially
available spreadsheet package for personal computers, based on a BIC
single pool volume variable according to the actual BIC plasma values
(BICb) and to the ultrafiltration (UF), and computing diffusive BIC
clearance on actual patient plasma water by in vitro data. Knowing the
patient's initial BICb, weight and hematocrit, the dialysis duration,
blood flow, fluid reinfusion rate and BIC content and the total ultrafil-
tration, the model computes the single minute intradialytic values of
plasma bicarbonate (BICb) and BIC mass balance (BICm). On 35
patients from seven Dialysis Centers, in 189 sessions, by AN69 filters of
1.6 and 1.2 m2, the end-session expected BICb (E-BIC) have been
compared to the observed ones (0-BIC): E-BIC were correlated with
O-BICb (0 = E x 0.80 + 5,06; r = 0.62) with a standard error (SE) of
2.0 mEq/liter versus an intralaboratory assay SE value of 0,9 mEq/liter.
The E-O BICb differences were normally distributed with a non-
significant mean value of 0.4 1.9 mEq/liter and, by a multiple
regression, were shown to be correlated with decreasing PCO2. The
model differentiated among sessions of similar BICb profiles and
different BICm, ranging from negative (—50 mEq) to positive values
(250 mEq), probably related to different situations of protein catabo-
lism. In conclusion, the model data showed a satisfactory degree of
precision and an accuracy expectedly lower than that of the intralabo-
ratory assay. In the clinical use, the model simulates sessions of
markedly different BICb profiles, allows individualizing dialysis pre-
scriptions and helps in understanding uncommon acid-base clinical
situations.
Evaluation of ionized calcium (ICa)-PTH curve in dialysis patients
using polynomial (P) and linear (L) regression analysis (RA). B. Pagliari,
F. Malberti, A. Sidoti, A. Baretta, C. Colturi, V. Dc Cristofaro, Renal
Units, Sondrio and Lodi, Italy. The construction of the sigmoidal
ICa-PTH curve and the determination of the set point of calcium are
useful parameters to represent the functional activity of the parathyroid
glands. The sigmoidal relationship between ICa and PTH is mathemat-
ically described by a 4th to 5th degree polynomial equation. The
transformation of the sigmoidal curve in a straight line expressed by a
simpler equation (that is, y = a + bx) is useful and desirable,
particularly when the statistical analysis is required to evaluate differ-
ences between two or more curves. In this study the PTH values,
expressed as % of the maximal PTH induced by hypocalcemia, were
transformed in probits or logits, and the L-RA between ICa (x) and
probits or logits (y) was used to determine the set point of Ca (= ICa
value at which maximal PTH is decreased by 50%). The set points of Ca
obtained using L-RA were compared with those obtained using P-RA.
The ICa-PTH curves were obtained inducing hypo- and hypercalcemia
by low and high Ca dialysis in 16 hemodialised patients, or by infusing
NaEDTA (20 mg/kg/hr for 150 ruin) and CaCI2 (5 mg/kg/hr of Ca for
150 mm) in four CAPD patients. The correlation coefficient range was
0.91 to 0.99 (X x Sn: 0.96 0.02) using P-RA and 0.8 to 0.98 (0.93
0.03) and 0.80 to 0.98 (0.91 0.03) using L-RA with probits or logits.
The set point of Ca determined by L-RA, using the transformation of
PTH% in probit and lobit, ranged between 1.22 and 1.47 mmol/liter and
1.22 to 1.59 mmol/liter, and it was significantly correlated (r = 0.97 and
0.92, P < 0.001) with the set point obtained by P-RA (range: 1.21 to
1.45). The slope (b) of the lines ranged between —5 and —24 logit/mmol
Ca and between —3.1 and —13.7 probit/mmo1Ca. Conclusions: (1)
The linear transformation of the sigmoidal ICa-PTH curve is possible
expressing the PTH% values as logit or probit, (2) The set point of Ca
obtained by L-RA is comparable to that obtained by P-RA.
Characterization of the antigen recognized by anti-mesangial cell
antibodies in IgA mesangial nephropathy (IgA-GN). C. Pinerolo, P.
Bernasconi, A. Fornasieri, S. Armelloni, M. Li, C. Pozzi, G. D'Amico.
Department of Nephrology and Immunohaematology, San Carlo Hos-
pital, Milano, Italy. We have recently confirmed the presence of IgG
antibodies (Ab) with specificity for mesangial cell (MC) constituents in
patients with IgA-GN. In order to characterize the antigen (Ag)
involved in this process, the antigenic extract, obtained by sonication of
human MC in culture, has been fractioned on a TSK 3000 HPLC
column. The main peaks between 1,000 and 300,000 Daltons were
coated at the concentration of 10 ig/ml on microtiter plates and assayed
by ELISA with positive and control sera. SDS electrophoresis of the
MC extract and immunoblotting of positive and control sera were also
performed. A significant binding of IgG was found with components of
molecular weight between 50,000 to 25,000 daltons with both HPLC-
ELISA and immunoblotting. In the same group of patients sera were
tested for the presence of anti-endothelial cell (EC) Ab; IgG anti-EC
were detected in 25/62 patients, IgA anti-EC in 24/46 patients. Corre-
lation between IgA- and IgG-anti-EC was poor (r = 0.48), while
between IgG anti-MC and IgG anti-EC was high (r = 0.66). Further-
more, preincubation of lgG anti-MC positive sera with EC in culture
inhibited anti-MC activity. Our results confirm the presence of IgG
anti-MC, IgA anti-EC and IgG anti-EC in IgA-GN. The Ag recognized
by tgG autoAb could be shared by MC and EC.
Peritoneal extraction of creatinine and beta2 microglobulin (p2): Com-
parison between continuous ambulatory peritoneal dialysis (CAPD) and
automatized peritoneal dialysis (APD). M. Ragaiolo, V. Petrucci, F.
Bruni, C.Q. Damiani, E. Pa/a, A. Case/li, V. Trovarelli, G. Fioravanti,
M. Antonelli, P. Manieri, Nephrology-Dialysis Department, "C. e G.
Mazzoni" Hospital, Ascoli Piceno, Italy. The peritoneal extraction of
both creatinine and $2 may help assess the body clearance of small and
medium-sized molecules in peritoneal dialysis patients. In order to
assess the suitability of dialytic methods, we compared the extraction of
the said substances in patients who were on CAPD first, and then on
APD. The study was carried out on fourteen patients (8 men and 6
women) whose average age was 63.8 9.8 years and average dialytic
age 28.7 13 months. Two patients were suffering from vascular
kidney disease, four from glomerulonephritis, six from pyelonephritis,
and two from cystic kidney disease. The patients were all on their first
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dialytic experience and were treated with four daily exchanges on
CAPD, where 2 liters of 2.27 and 1.36 solutions were used alternatively.
The study consisted in assaying creatinine level (adjusted according to
our lab's adjustment factor) in peritoneal liquid and /32 level in the
draining liquid from CAPD exchanges. The same patients were even-
tually treated with a session of night peritoneal dialysis (NPD) with a
dialyzer volume per cycle of 1.8 0.2 liters, 5.8 1.1 cycles, 80.7
33.5 minutes of dwelling time, and an average of 5.57 2.5 liters of
1.36; 4.4 2.2 liters of 2.27; 5.25 0.5 liters of 3.86. Creatinine and /32
were then assayed in the drained liquid from NPD. The creatinine
extracted on CAPD averaged 591.1 148.2 mg as a total rate for the
four exchanges. The creatinine extracted on NPD was 457.2 184.1
mg. A statistical comparison between the two average figures was
significant for a P < 0.0065. By adding NPD extraction with the
extraction from the 8.00 to 12.00 exchange, we have a total extraction
of 620.1 208.7 mg., which is higher than the CAPD rate, but has no
statistical significance. /32 CAPD extraction averaged 39.9 13.1 mg.
Extracting /32 on NPD resulted in a 18.5 12.4 mg rate, having a
remarkable statistic difference and a P < 0.0001. By adding the 132 rate
extracted on NPD with the /32 rate from the 8.00 to 12.00 exchange we
have a 28.79 15.06 mg rate, which is still remarkably lower than the
CAPD extraction rate (P < 0.0004). The CAPD extraction figure is only
equalled if adding PACX extraction with the night-time exchange figure
(37.79 17.56 mg). A fractioned extraction of both creatinine and /2
globulin shows how the former depends on ultrafiltrate and the latter on
dwelling time. The extraction of small molecules on NPD is therefore
lower than on CAPD, yet a good clearance performance may be
attained by either increasing the quantity of the exchange liquid and/or
adjusting NPD features according to the equilibrium test and/or finally
increasing the treatment by a four-hour exchange. A /32 clearance
involves more complex considerations, since an APD treatment causes
a sharp clearance decrease, possibly due to the clearance depending on
the dwelling time of the liquid rather than on quantity. CAPD perfor-
mance appears to be only equalled by NPD if adding the latter with a
12-hour continuous exchange.
Effects of 1,25(OH)2 P3 on monocytes/macrophages. D. Roccatello, C.
Isidoro, A. Mesiti, D. De Stefanis, M. Demoz, D. Alessi, G. Quattroc-
chio, A. Molino, F.M. Baccino, G. Piccoli, Istituto di Nefro-Urologia e
Dip. di Medicina ed Oncologia Sperimentale, Sez. Pat. Gen. Universitd
di Torino, Italy. In addition to its well known role in mineral and
skeletal homeostasis, 1, 25 dihydroxyvitamin D3 [1, 25 (OH)2 D3]
regulates the differentiation, growth and function of a broad range of
cells. The effects of 1, 25 (OH)2 D3 on synthesis and transport of
cathepsin D (C-D), one of the most important lysosomal proteases of
monocyte/macrophage-related cells, were determined in six uremic still
undialyzed patients (pts) with creatinine values 440 pinol/liter. Re-
sults were compared to those from six age-matched healthy subjects.
Monocytes, isolated by Ficoll-Hypaque gradient and adherence to
Petri's plates, were maintained in culture for three days. Adherent cells
were metabolically labeled with S-methionine in absence or in presence
of 0.1 mol/liter of 1, 25 (OH)2 D3. C-D was immune-precipitated from
medium and cell extracts and the radioactive polypeptides analyzed by
electrophoresis in 12.5% polyacrylamide gel followed by fluorography.
Compared to normal, cultured monocytes from uremic pts showed an
increase in secretion of both mature (31 KD) and immature (53 KD)
forms of C-D, thus suggesting an altered transport of lysosomal
enzyme. 1, 25 (OH)2 D3 was found to promote maturation (and
consequently secretion of mature C-D) in normals. These effects were
incompletely exerted on monocytes from uremic pts. 1, 25 (OH)2 D3
only partially corrects abnormalities in biogenesis of this lysosomal
enzyme in uremic monocytes. Due to the role of monocyte-denved cells
in bone metabolism, these data could have relevant implications, not
only in the pathophysiology of the impaired phagocytosis of uremic
monocytes, but even in the general phenomenon of bone reabsorbtion.
Kinetics and fate of cryoglobulins in patients with essential mixed
cryoglobulinemia. D. Roccatello, G. Picciorto, R. Ropolo, G. Cacace,
PG. De Filippi, G. Quattrocchio, M. Ferro, A. Vallero, F. Pignone, G.
Gigliola, G. Giraudo, G. Piccoli, Istituto di Nefro-Urologia, Universitd
di Torino e Servizio di Medicina Nucleare, Ospedale G. Battista,
Torino, Italy. In vivo kinetics and fate of autologous cryoglobulins were
analyzed in nine essential mixed cryoglobulinemia (EMC) patients
(pts): two without renal involvement, four with EMC-associated, biop-
sy-proven glomerulonephritis (GM) in phase of therapy-induced clinical
inactivity, and three with clinically active EMC-associated, still un-
treated, mesangiocapillary GN. Patients gave informed consent and the
study was approved by the local Ethic Committee. Patients were
intravenously injected with 100 .tl of 8 mg/mi autologous cryoglobulins
labeled with 37 to 55 mBq of 123lodine. Time course of radioactivity in
circulation and organ uptake were measured by gamma-camera (Star-
gem SP General Electric on line with a starview computer) and by
counting sequential samples of plasma and packed erythrocytes. Eryth-
rocyte transport system was found to be excluded by clearance kinet-
ics. Heart activity/time decline, regarded as representative of blood
clearance, could be fitted by a biexponential curve, whose slopes
respectively reflected dilution of the tracer in the intravascular pool
(lambda 1) and disappearance of cryoglobulins after distribution, and
therefore blood clearance (lambda 2). Compared to EMC pts without
renal involvement or with inactive GN, EMC-associated active GN pts
had lambda 2 values remarkably less negative (mean 0.008 min1 vs.
0.014 and 0.02, respectively) and a mean half-time of cryoglobulins in
circulation correspondingly prolonged. Liver accumulation was found
to be predominant and approximated a gamma variate function with a
mean transit time more prolonged in EMC-associated active GN pts
than in the other two groups (mean 252.6 mm vs. 53.5 and 56.1).
Contrary to non-nephritic and inactive GN pts, the cases with EMC-
associated active GM were also characterized by virtually absent
uptake of cryoglobulins by spleen, This report demonstrates reduced
uptake and catabolism of cryoglobulins in pts with EMC-associated
clinically active GN.
Intracellular pH (pHi) regulation in hypercalciuric calcium stone
formers (CSF). G. Rombolâ, G. Colussi, C. Airaghi, ME. De Ferrari,
and L. Minetti, Renal Unit, EQ. Niguarda-Ca' Granda, Milan, Italy.
An increased oxalate transport in the cellular membrane of red blood
cells through the anion transport system "band 3" in CSF patients has
recently been found. Among the other functions of the "band 3"
system, the participation to the regulation of Cl and HCO3 movements
across the cellular membrane is a very important one, thus, even pHi
regulation might be affected by the mentioned defect in CSF. We have
evaluated using the fluorescent probe BCECF: resting pHi, buffering
power (BP; mmol/lcellIpH), and the effect on pHi of five minutes of
exposure to Na free medium (pHi; pHunit/5 mm) in peripheral
lymphocytes, in 39 CSF and 37 age and sex matched healthy controls
(C). The pHi measurements were performed both in the presence of
HCO3-CO2 and in its absence (HEPES pH 7.4). The cells were loaded
at 37°C for 30 minutes and the BCECF fluorescence was continually
recorded (emission 525 nm) at two exitation wavelengths of 440 and 500
nm. A calibration curve for BCECF fluorescence has been performed
using nigencin in a KC1 buffer. Choline substitute for Na in Na free
buffers.
Measurements in HEPES buffer
N pHi BP pHi Na free
C
CSF
(20)
(15)
7.20 0.02 35.4 6.7 —0.16 0.03
7.23 0.03 49.0 15.4 —0.29 0.06
C
CSF
(17)
(24)
Measurements in HCO3-C02 buffer
7.34 004b 86.2 4.2 —0.13 0.05
7.23 0.02° 70.7 4.0 —0.12 0.03
a P < 0.05 vs C; b P < 0.05 vs. HEPES buffer
Conclusions: In C, but not in CSF, pHi was higher in the presence of
HCO1-C02 than in its absence. In the absence of Na, pHi fell in both C
and CSF and in both buffers; the fall was the same in the presence of
HCO3-C02, whereas in absence of HCO3-C02 it was significantly
greater in CSF. Our study shows some abnormalities, as yet undefined,
in the membrane transport system(s) involved in the regulation of pHi
in CSF.
Prevalence of microalbuminuria (MA) in non-insulin dependent diabe-
tes mellitus (NIDDM) in Genoa, Italy. S. Saffioti, V. Cheli, R. Pontrem-
oh, P. Moscatelhi, A. De Michehi, C. Bordone, L. Cataldi, G. Deferrari,
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Department of Internal Medicine, University of Genoa, and Diabetes
Unit, S. Martino Hospital, Genoa, Italy. The prevalence of diabetic
nephropathy in NIDDM varies between 10 and 40% according to
different reports Only a few data are available on the prevalence of MA
as a marker for clinical nephropathy. The aim of this study was to
evaluate the prevalence of MA in a population of NIDDM from Genoa.
Three hundred sixteen NIDDM patients (164 males, 136 females), mean
age 61 6 years (range 38 to 70), mean duration of disease 10 8 years
(range 1 to 38), in good metabolic control (mean HbAlc 7.7%) and
without urinary tract infection participated in the study. The following
parameters were evaluated: the presence of MA (albuminlcreatinine
ratio > 2.7) on a morning urinary specimen (in at least two out of three
non-consecutive samples), of retinopathy by funduscopic examination,
somatic neuropathy by vibration perception test, arterial hypertension(blood pressure > 140/90 mm Hg), and lipid profile. Micro- and
macroalbuminuria were present in 12 and 6.6% of NIDDM patients,
respectively and were slightly more prevalent in males; furthermore,
they were positively correlated with age but not with duration of
diabetes. In the subgroup of hypertensive patients (53%), the preva-
lence of albuminuria was 15.4% compared to 10.1% in normotensive
patients. Signs of retinopathy were present in 30% of patients, while
53% of patients showed signs of peripheral neuropathy. These compli-
cations were slightly associated with the presence of MA. The preva-
lence of MA in the area of Genoa is lower than that reported in other
European studies. The long-term follow-up will allow us to clarify the
usefulness of MA as an early marker of nephropathy in NIDDM.
Changing the pattern in rapidly progressive glomerulonephritis
(RPGN). P. Stratta, C. Canavese, M. Dogliani, A. Thea, G. Mazzucco,
G. Monga, S. Ferrero, and A. Vercellone. Department of Nephrology
and Biomedical Science, University of Torino, Italy. Glomerular vas-
culitis (VSCL) associated with acute renal failure defined as type III
RPGN is suggested as occurring with an increased frequency in last
years. RPGN profile in 58 cases observed in the two periods 1975—1982
and 1983—1990 shows a true increase in frequency for type III from 48%
to 75%, versus 12% and 12% (type I) and 40% and 12% (type II). Type
III RPGN was diagnosed in two Wegener, 10 microscopic PAN, and 25
cases with only glomerular involvement (7 necrotizing and 9 crescentic
GN). Type Ill RPGN was characterized by older age (60.4 26 vs. 47.7
20 and 45.2 16 years), higher mortality (35% vs. 14% and 0), lower
request for HD (54% vs. 85% and 78%), greater frequency of renal
recovery (30% vs. 0 and 9%), and previous pulmonary disease as high
as for type I (32% vs. 42%). In summary: (1) Type III RPGN is an
increasingly frequent disease with a distinctive pattern from other
RPGN; (2) Necrosis as well as crescents without necrosis may repre-
sent histological patterns of this glomerulus-confined VSCL.
Characterization of anti-myeloperoxidase (MPO) antibodies (Abs) in
vasculitis. M. Tadros, C. Pozzi, A. Radice, R.A. Sinico, G. D'Amico,
Department of Nephrology, S.Carlo Hospital, Milan, Italy. To charac-
terize the pattern of reactivity of anti-MPO Abs, sera from 72 patients
with vasculitis (with anti-MPO Abs by ELISA) were examined by
Western blot and by competition studies using an anti-MPO monoclonal
Ab (MoAb) (DAKO). Eighty-five percent of sera (17/20) reacted with
native MPO (non-reduced; 120 Kd). No reactivity was present in blots
run under reducing conditions (denaturated MPO). The anti-MPO
MoAb showed the same pattern of reactivity as the positive human
sera, whereas a goat polyclonal anti-MPO anti-serum (DAKO) recog-
nized both native and denaturated MPO. Sixty-one percent (44/72) of
sera were able to inhibit the binding of the anti-MPO MoAb to
MPO-coated wells, showing that they react with the same epitope
recognized by the anti-MPO MoAb. There was no correlation between
the titer of anti-MPO Abs and the presence or degree of positivity by
Western blot analysis. Correlation between the anti-MPO Ab titer and
degree of inhibitory activity was at the limits of significance. Our data
suggest that anti-MPO Abs recognize conformational epitope(s), and
that in more than half of the patients one of the epitopes is the same as
that recognized by the anti-MPO MoAb; the absence of inhibitory
activity in 40% of sera indicates that other epitope(s) are involved in
anti-MPO Ab/MPO reactivity. The clinical significance of this hetero-
genicity in anti-MPO autoAbs remains to be elucidated.
"Nondippers" and progression of chronic renal insufficiency (CR!). M.
Timio, S. Lolli, C. Monarca, C. Verdura, E. Guerrini, Department of
Internal Medicine and Nephrology, Foligno, Italy. Clinical studies
performed with non-invasive ambulatory blood pressure (BP) monitor-
ing have shown a disturbance in the 24 hour profile of SBP/DBP, with
nocturnal pressure decline significantly reduced or blunted in patients
with CR1 ("nondippers"). We addressed this issue in a reproducibility
study in which 21 normotensive patients with stable CR!, defined as
"nondippers" according to 24 hour BP monitoring (Spacelabs 90202)
readings, were followed-up to assess the influence of abnormal BP
circadian rhythm on CR1 progression. A control group included 16
selected normotensive uremic patients with BP "dippers" pattern
(nocturnal decline >10% of day-time values). The two groups were pair
matched for age, sex, body mass index, causal BP, underlying renal
diseases, creatinine clearance (Car), low-protein diet (0.6 g/kg body wt
daily). Patients underwent BP 24-hour monitoring, Ccr measurement
and 24 hour urinary protein excretion, repeated every four months for
two years. During the study the abnormal decline in nocturnal BP
persisted in 96% of "nondippers". After two years the progression of
CR1 was higher in 'nondippers" than in "dippers" (Car 0.29 vs. 0.19
mI/mm/month: P < 0.001); so was the increasing of proteinuria (628
69 vs. 403 52 mg/24 hr; P <0.01). The results of our study show that
the progression of CR1 in normotensive uremic patients is more
dependent on night-time than day-time BP values. In addition they
suggest that the abrogation of a regular circadian rhythm is not
compatible with the diagnosis of normotension despite the normality of
day-time BP. Therefore "nondipper" normotensive uremics call for a
proper treatment aimed at reducing night-time BP and contributing to
renal protection.
Erythrocyte Ca transports in idiopathic hypercalciuria. G. Vezzoli,
MC. Reina, T. Stellato, P. Casirati, and G. Bianchi. Department of
Nephrology, H.S. Raffaele, University of Milan, Italy. In order to
evaluate cellular Ca metabolism in patients with idiopathic hypercalci-
uria (IH), we studied plasma membrane Ca pump (CaATPase) and
passive influx of bivalent cations in the erythrocytes (RBC) of 15
hypercalciuric patients with Ca-oxalate nephrolithiasis and in 20 nor-
mocalciuric subjects with Ca-oxalate nephrolitiasis (UCa < 0.1 mM/kg
body wt per day). CaATPase was measured at maX as ATP hidrolyzed
by erythrocyte membranes in the presence of free Ca 10 /.LM and
Calmodulin 1 sg/ml. Ca influx was evaluated as Sr influx into RBC
incubated in isotonic medium with 5r m and Vanadate 3 mM
(CaATPase inhibitor). Electrolytes were determined in plasma and
urine; PTH was measured in plasma; the intestinal Ca absorption was
evaluated as absorbed fraction of an oral load of stable S (2.65 mg per
kg of body wt) after one and four hours. Our results showed a
significatively higher CaATPase activity in the patients with IH (54
4.5 vs. 43 3.8 nmoles ATP split/mm per mg of proteins [my SE]; P
<0.05). Sr influx was not different in the two groups (4.6 0.6 vs. 4.7
0.6 tmoles/IRBC per mm). Intestinal r absorption was higher in the
patientswithlHatthefirsthour(l6.9 1.3%vs. 13.5 l%;P<0.05),
but not at the fourth hour (20 1.6% vs. 19 1.2%). Moreover, the
patients with IH showed Na, K and P excretion more elevated than in
normocalciuric subjects. These results suggest that IH is associated
with increased values of erythrocyte CaATPase. As erythrocyte 5r
influx, a marker of Ca influx, is not different in normo- and hypercal-
ciuric subjects, the defect of plasma membrane CaATPase may be
primitive and genetically determined.
